Insider trade

Director sold ~$851K of IBRX shares in the open market

Traded Oct 2, 2026 · Filed Oct 6, 2026

Why it stands out

A board member of Immunitybio sold $851K of Immunitybio shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$851,088

Shares × reported transaction price

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 27, 2026.

Scheduled in advanceyesterday

yesterday

Derivative exercise or conversion — not an open-market buy.

yesterday

Derivative exercise or conversion — not an open-market buy.